Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study

NCT02719041 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT02719041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study
Lead sponsor
Hillel Yaffe Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2016
Completion date
April 30, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer